I found my blog of "theUniversity of Hong Kong found radical hepatitis B
drug"posted previously in Chinese simplified wording "根治乙肝药物"
were grossly exaggerated and misinterpreted. I have used Epivir for
more than 10 years. Based on my understanding the phrase
** 根治乙肝药物 **must be proved by scientific medical tests
as follows:
1. HBsAg (hepatitis B surface antigen) A "positive" or "reactive"
HBsAb (or anti-HBs) test result indicates that a person has
successfully responded to the hepatitis B vaccine or has
recovered from an acute hepatitis B infection.
This result means that you are immune to future hepatitis B
infection and you are not contagious.
2. HBsAb or Anti-HBs (hepatitis B surface antibody)
The HBcAb is an antibody that is part of the virus- it does not
provide protection. A "positive" or "reactive" HBcAb
(or anti-HBc) test result indicates a past or present infection,
but it could also be a false positive. The interpretation of this
test result depends on the results of the other two tests.
Its appearance with the protective surface antibody
(positive HBsAb or anti-HBs) indicates prior infection
and recovery. For chronically infected persons,
it will usually appear with the virus (positive HBsAg).
3. HBcAb or anti-HBc (hepatitis B core antibody)
The HBcAb is an antibody that is part of the virus-
it does not provide protection. A "positive" or "reactive"
HBcAb (or anti-HBc) test result indicates a past or present
infection, but it could also be a false positive. The interpretation
of this test result depends on the results of the other two tests.
Its appearance with the protective surface antibody
(positive HBsAb or anti-HBs) indicates prior infection
and recovery. For chronically infected persons.
4. Hepatic function panel testing results must be all normal.
5. CBC tests including Platelet must be normal range
(140~400k/ul). Lower than 140 indicates that virus still
remains in your body.
6. hepatitis B patients required every six months for one
blood test AFP ( A cancer marker.)and ultrasound. I apologize to the those misinterpretation but maintain that news
remains encouraging development in the field of fighting HBV.
| 
字體：小 中 大
